Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study
Authors:
- Stavros V. KonstantinidesSKStavros V. Konstantinides
- Stefano BarcoSBStefano Barco
- Stephan RosenkranzSRStephan Rosenkranz
- Mareike LankeitMLMareike Lankeit
- Matthias HeldMHMatthias Held
- Felix GerhardtFGFelix Gerhardt
- Leonard BruchLBLeonard Bruch
- Ralf EwertRERalf Ewert
- Martin FaehlingMFMartin Faehling
- Julia FreiseJFJulia Freise
- Hossein-Ardeschir GhofraniHGHossein-Ardeschir Ghofrani
- Ekkehard GrünigEGEkkehard Grünig
Open Access
- 30 August 2016
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 42 (4) , 600-609
Abstract
Acute pulmonary embolism (PE) is a frequent cause of death and serious disability. The risk of PE-associated mortality and morbidity extends far beyond the acute phase of the disease. In earlier follow-up studies, as many as 30 % of the patients died during a follow-up period of up to 3 years, and up to 50 % of patients continued to complain of dyspnea and/or poor physical performance 6 months to 3 years after the index event. The most feared ‘late sequela’ of PE is chronic thromboembolic pulmonary hypertension (CTEPH), the true incidence of which remains obscure due to the large margin of error in the rates reported by mostly small, single-center studies. Moreover, the functional and hemodynamic changes corresponding to early, possibly reversible stages of CTEPH, have not been systematically investigated. The ongoing Follow-Up after acute pulmonary embolism (FOCUS) study will prospectively enroll and systematically follow, over a 2-year period and with a standardized comprehensive program of clinical, echocardiographic, functional and laboratory testing, a large multicenter prospective cohort of 1000 unselected patients (all-comers) with acute symptomatic PE. FOCUS will possess adequate power to provide answers to relevant remaining questions regarding the patients’ long-term morbidity and mortality, and the temporal pattern of post-PE abnormalities. It will hopefully provide evidence for future guideline recommendations regarding the selection of patients for long-term follow-up after PE, the modalities which this follow-up should include, and the findings that should be interpreted as indicating progressive functional and hemodynamic post-PE impairment, or the development of CTEPH.Keywords
Funding Information
- University Medical Center of the Johannes Gutenberg University, Mainz, Germany
- German Federal Ministry of Education and Research (BMBF 01EO1003 and 01EO1503)
- Bayer HealthCare
- Bayer Pharma AG
This publication has 33 references indexed in Scilit:
- Functional Characterization of Patients with Chronic Thromboembolic DiseaseRespiration, 2016
- Trends in incidence versus case fatality rates of pulmonary embolism: Good news or bad news?Thrombosis and Haemostasis, 2016
- European Union-28: An annualised cost-of-illness model for venous thromboembolismThrombosis and Haemostasis, 2016
- The post-PE syndrome: a new concept for chronic complications of pulmonary embolismBlood Reviews, 2014
- Cardiopulmonary Exercise Testing to Detect Chronic Thromboembolic Pulmonary Hypertension in Patients with Normal EchocardiographyRespiration, 2014
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolismInternal and Emergency Medicine, 2011
- Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2010
- Natural History of Right Ventricular Dysfunction After Acute Pulmonary EmbolismJournal of the American Society of Echocardiography, 2007
- Resolution of Thromboemboli in Patients With Acute Pulmonary EmbolismChest, 2006